findmyKOL

Catherine Yang, MD

Basic profile

Brigham and Women's Hospital

ORCIDNone on fileNPI
RegionBoston, MA · NortheastSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Catherine Yang is a Dermatology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 25 publications with 345 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
25publications

Distinct works indexed by OpenAlex.

345citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

221 Longwood Ave
Department Of Dermatology
Boston, MA 021155804

Telephone

617-732-4918

Registry record last updated 31 Oct 2016.

View the NPPES registry record

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    34%
    Azole Antifungal18.2%
    Ketoconazole100%
    Part D64 patients
    Nitroimidazole Antimicrobial8.1%
    Metronidazole100%
    Part D25 patients

    + 3 more classes in this area

  • Dermatology

    26.5%
    Corticosteroid20.3%
    Triamcinolone Acetonide78%Halobetasol Propionate22%
    Part D78 patients
    Interleukin-4 Receptor alpha Antagonist6.2%
    Dupixent Pen54%Dupixent Syringe47%
    Part D<11 patients
  • Cancer & immunology

    23.6%
    Calcineurin inhibitor7.6%
    Tacrolimus100%
    Part D26 patients
    Nucleoside Metabolic Inhibitor5.5%
    Fluorouracil100%
    Part D32 patients

    + 4 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”